lung, breast, kidney, represent phenotypic diversity like cell surface markers, molecular mutations (p53, PTEN, ER), demonstrate varied growth rate and apoptosis based on the cancer microenvironment and status of blood supply, and its aggressive nature. The gene discussed is TP53; the disease is cancer.